Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Location

Market Cap

USD 7.51 B

Share Price

USD 15.18

Avg Daily Volume

3,111,760

Change (1 day)

2.64%

Change (1 year)

12.44%

Change (YTD)

207.29%

Regencell Bioscience Holdings Limited EBITDA Margin for the Trailing 12 Months (TTM) ending July 26, 2025: N/A

Regencell Bioscience Holdings Limited EBITDA Margin is NA for the Trailing 12 Months (TTM) ending July 26, 2025. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin